News

Kalion Inc. Teams with Agile BioFoundry To Win DOE Grant to Advance Bio-based Glucaric Acid

Kalion Inc., along with 8 other companies, was selected by the U.S. Department of Energy to receive $5.7 million in funding with the Agile BioFoundry consortium (agilebiofoundry.org) to advance the fundamental understanding of industrial biotechnology. Kalion Inc. uses machine learning to accelerate the development of high-purity, low-cost glucaric acid. Read more >>
Read more...

Boulder JCC Nosh & Network Panel Discussion: Pivot Business To Possibility

On Wednesday, October 28 from 4:00 – 5:30 pm, we will host a panel discussion on the ways in which COVID-19 required businesses to revisit the way their work is done, including reassessing, reshaping, and refocusing. Four Boulder businesses will share their experience and how they expect their business will change going forward. Panel includes 1908 Brands. Read more >>
Read more...

The Active Fund at Boston Harbor Angels

Boston Harbor Angels launched in 2018 an investment platform for its members and accredited investors " The Active Fund". The Active Fund allows members and accredited investors to invest and support startups in the Boston Harbor Angels ecosystem. "The Active Fund is a private platform allowing a lot of flexibility to our members" said Ziad Moukheiber President of Boston Harbor Angels.
Read more...

Kalion Inc. Teams with Agile BioFoundry To Win DOE Grant to Advance Bio-based Glucaric Acid

Kalion Inc., along with 8 other companies, was selected by the U.S. Department of Energy to receive $5.7 million in funding with the Agile BioFoundry consortium (agilebiofoundry.org) to advance the fundamental understanding of industrial biotechnology. Kalion Inc. uses machine learning to accelerate the development of high-purity, low-cost glucaric acid. Read more >>
Read more...

First Light Diagnostics Receives Additional Funding from the Biomedical Advanced Research and Development Authority (BARDA)

First Light Diagnostics, Inc., a developer of breakthrough automated products for the rapid diagnosis and treatment of life-threatening infections, today announced the authorization of a $4 million award from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. These funds will continue BARDA’s support of First Light Diagnostics’ proprietary MultiPath™ platform and a rapid ultrasensitive test to identify victims of...
Read more...

eSight Earns International Recognition For New Medical Device, Workplace Assistive Technology Program

Leading vision-enhancement company, eSight, has won two awards for its eSight Workplace program, which provides an all-in-one assistive device with a comprehensive support program, enabling companies to easily and cost-effectively empower employees with serious visual impairments. The awards recognized eSight for quickly developing the program in response to the COVID-19 pandemic. Read more >>
Read more...

Investing for a Better World

For over 15 years the Boston Harbor Angels have been investing in companies that are making the world a better place through their innovation and hard work. Ziad Moukheiber President of BHA said "One of my favorite questions our members always ask is , how does your company make the world a better place?". #investinginabetterworld
Read more...

Carbonite teams with CloudHappi to bring free server migration to the education market

Cloud backup firm Carbonite has partnered with CloudHappi, an organization that specializes in IT solutions for the education sector, to provide free server migration for schools in the UK. The migration service will be offered free-of-charge and should speed up the transition from on-premise IT to cloud-based services. Read more >>
Read more...

Corbus Pharmaceuticals Announces Presentation of Data from its Phase 2b Study in Cystic Fibrosis at NACFC 2020

Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced the presentation of the preliminary data from its 28 week Phase 2b study of lenabasum in patients with cystic fibrosis (CF) at the North American Cystic Fibrosis Conference (NACFC) held online, Oct 7-23, 2020. Read more >>
Read more...

Regroup Mass Notification Wins 2020 Mobile Star Awards from Mobile Village

Regroup Mass Notification, a trusted provider of emergency and day-to-day mass notification solutions, today announced that it has been named a winner of the 2020 Mobile Star Awards in the "Innovative Mobile Mass Notification & Response" category. The Mobile Star Awards is one of the largest, longest-running programs acknowledging mobile innovators, apps, and software. Read more >>
Read more...